Eloi Gagnon

Quebec, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease.

Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease.

Journal: The Journal of clinical endocrinology and metabolism

Published: August 13, 2025

Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study.

Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study.

Journal: Circulation. Genomic and precision medicine

Published: March 07, 2025

Leveraging drug-target Mendelian randomization for tailored lipoprotein-lipid lowering.

Leveraging drug-target Mendelian randomization for tailored lipoprotein-lipid lowering.

Journal: Current opinion in lipidology

Published: February 20, 2025

Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.

Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.

Journal: Circulation

Published: February 03, 2025

Remnant cholesterol concentrations best explain the cardiovascular benefit of APOC3 genetic inhibition: a drug target Mendelian randomization study.

Remnant cholesterol concentrations best explain the cardiovascular benefit of APOC3 genetic inhibition: a drug target Mendelian randomization study.

Journal: European heart journal open

Published: December 17, 2024

Common pitfalls in drug target Mendelian randomization and how to avoid them.

Common pitfalls in drug target Mendelian randomization and how to avoid them.

Journal: BMC medicine

Published: August 01, 2024

RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study.

RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study.

Journal: Cardiovascular research

Published: June 14, 2024

Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence.

Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence.

Journal: Atherosclerosis

Published: April 29, 2024

Pancreatitis polygenic risk score is independently associated with all-cause acute pancreatitis risk in the UK Biobank.

Pancreatitis polygenic risk score is independently associated with all-cause acute pancreatitis risk in the UK Biobank.

Journal: Journal of gastroenterology and hepatology

Published: April 18, 2024

Appraisal of multiple polygenic risk scores to estimate the risk of myocardial infarction and coronary artery lesions.

Appraisal of multiple polygenic risk scores to estimate the risk of myocardial infarction and coronary artery lesions.

Journal: Communications medicine

Published: March 27, 2024

Impact of loss-of-function in angiopoietin-like 4 on the human phenome.

Impact of loss-of-function in angiopoietin-like 4 on the human phenome.

Journal: Atherosclerosis

Published: February 14, 2024

Mendelian Randomization Applied to Neurology: Promises and Challenges

Mendelian Randomization Applied to Neurology: Promises and Challenges

Journal: Neurology

Published: January 23, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026